PUBLISHER: The Business Research Company | PRODUCT CODE: 1945228
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945228
Gastroenteritis testing includes diagnostic methods used to identify the cause of inflammation in the stomach and intestines. Since gastroenteritis can result from viruses, bacteria, or parasites, these tests help determine the cause and guide appropriate treatment such as antibiotics, antivirals, or supportive care.
The major types of gastroenteritis testing include viral gastrointestinal infections, bacterial gastrointestinal infections, and parasitic gastrointestinal infections. Viral gastrointestinal infections are conditions caused by viruses affecting the stomach and intestines, resulting in symptoms such as diarrhea, vomiting, and abdominal discomfort. Testing is conducted for bacterial, viral, and parasitic strains using methods such as immunoassay testing, conventional testing, and molecular diagnostic testing. These tests are utilized by end users including hospitals, clinics or medical centers, research institutions, and diagnostic laboratories.
Tariffs are impacting the gastroenteritis testing market by increasing the cost of imported diagnostic reagents, molecular testing kits, and laboratory equipment. Segments such as molecular diagnostic testing and advanced immunoassay kits are most affected, with regions like Asia-Pacific, including China and India, facing significant import duties. This has led to higher operational costs and potential delays in testing kit availability. On the positive side, tariffs encourage local production of diagnostic kits and equipment, fostering innovation and boosting domestic manufacturing capabilities.
The gastroenteritis testing market research report is one of a series of new reports from The Business Research Company that provides gastroenteritis testing market statistics, including gastroenteritis testing industry global market size, regional shares, competitors with a gastroenteritis testing market share, detailed gastroenteritis testing market segments, market trends and opportunities, and any further data you may need to thrive in the gastroenteritis testing industry. This gastroenteritis testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The gastroenteritis testing market size has grown strongly in recent years. It will grow from $4.18 billion in 2025 to $4.44 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to reliance on conventional immunoassay and culture-based methods, limited availability of advanced molecular diagnostics, increasing prevalence of gastrointestinal infections, rising hospital and clinic diagnostic capabilities, expansion of research institutes in infectious disease studies.
The gastroenteritis testing market size is expected to see strong growth in the next few years. It will grow to $5.55 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to advancements in molecular diagnostic technologies, growing demand for rapid point-of-care testing, increasing funding for infectious disease research, rising adoption of integrated laboratory information systems, expansion of gastroenteritis testing in emerging markets. Major trends in the forecast period include increasing demand for rapid and accurate gastroenteritis diagnostics, rising adoption of molecular diagnostic testing methods, expansion of viral, bacterial, and parasitic testing panels, growth in point-of-care testing and hospital-based diagnostics, enhanced focus on epidemiological surveillance and outbreak management.
The rising incidence of bacterial infections is increasingly supporting the expansion of the gastroenteritis testing market going forward. Bacterial infections are becoming more prevalent due to increased antibiotic resistance, higher population density, and expanded global travel, which accelerates the spread of resistant pathogens. Gastroenteritis testing plays a critical role in identifying bacterial causes of symptoms such as diarrhea and vomiting, enabling appropriate treatment and helping prevent further transmission. For example, in 2024, according to GOV.UK, a UK-based government organization, cases of bacteraemia caused by antibiotic-resistant bacteria increased by 9.3% from 18,740 cases in 2023 to 20,484 cases in 2024. Consequently, the rising incidence of bacterial infections is reinforcing demand within the gastroenteritis testing market.
Leading companies operating in the gastroenteritis testing market are developing innovative solutions, such as molecular gastrointestinal panels, to deliver high sensitivity and specificity in pathogen detection. Molecular gastrointestinal tests use techniques such as polymerase chain reaction (PCR) to identify genetic material from pathogens in gastrointestinal samples. For example, in June 2024, QIAGEN N.V., a Germany-based provider of sample and assay technologies, launched the QIAstat-Dx Gastrointestinal Panel 2. This panel enables rapid detection of up to 16 bacterial, viral, and parasitic pathogens using real-time PCR, significantly reducing turnaround time compared with traditional culture-based diagnostic methods.
In December 2024, the Indian Council of Medical Research (ICMR), an India-based national medical research organization, entered into a partnership with Molbio Diagnostics Pvt. Ltd. to expand global access to advanced multiplex RT-PCR technology for detecting enteric viruses responsible for childhood gastroenteritis. This collaboration leverages Molbio's commercialization expertise and global diagnostic distribution network to improve accessibility. Molbio Diagnostics Pvt. Ltd. is an India-based provider of portable and rapid molecular diagnostic solutions designed to support timely disease detection across diverse healthcare environments.
Major companies operating in the gastroenteritis testing market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Abbott Diagnostics, Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., Eurofins Scientific SE, Hologic Inc., Becton Dickinson and Company, bioMerieux SA, Quest Diagnostics Incorporated, DiaSorin S.p.A., Bio-Rad Laboratories Inc., Randox Laboratories Ltd., ARUP Laboratories, Meridian Bioscience Inc., MedGenome, Trinity Biotech plc, Savyon Diagnostics Ltd., Coris BioConcept, Aster Clinical Research & Diagnostic Centre Pvt. Ltd., Alimetrix Inc., Luminex Corporation
North America was the largest region in the gastroenteritis testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroenteritis testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the gastroenteritis testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The gastroenteritis testing market consists of revenues earned by entities by providing services such as culture testing, imaging services, hydration assessment, and consultation and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastroenteritis testing market also includes sales of stool collection kits, rapid test kits, endoscopic equipment, and culture media. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Gastroenteritis Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses gastroenteritis testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for gastroenteritis testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gastroenteritis testing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.